Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)
No Thumbnail Available
Identifiers
Date
2020-03-01
Authors
Le Tourneau, C.
Rischin, D.
Groenland, S.
Lim, A.
Martin-Liberal, J.
Moreno, V.
Trigo, J. M.
Mathew, M.
Cho, D.
Hansen, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford univ press
Metrics
Export
